Salute e Benessere
Abu Dhabi is Underway to Become a Global Pharmaceutical and Life Science Distribution Hub
In line with the Abu Dhabi Economic Vision 2030, the MoU is a pivotal step in Abu Dhabi's ongoing efforts to become a leading healthcare destination in the global healthcare landscape. The strategic partnership aims to create attractive value propositions for pharmaceutical, biotechnology, and medical technology companies to establish their operations in Abu Dhabi . By capitalising on DoH's world-class regulatory framework, ADIO's attractive investment platform, Etihad Cargo's expertise in air freight, and AD Port's robust logistics infrastructure, the collaboration is set to position Abu Dhabi as a global healthcare and life-science distribution hub.
, was present at the signing and emphasised the importance of this initiative, stating, "Leveraging Abu Dhabi's strategic location at the gateway to the MENA region, we are pleased to partner with world-class leaders in investment and logistics, offering advanced infrastructure with easy access to regional and global markets. Our vision is to create a healthcare environment where patients have access to the latest treatments and medical technologies. By establishing a robust healthcare and life-science distribution hub, we are poised to enhance healthcare outcomes and improve lives across the region. The establishment of this distribution hub will not only solidify Abu Dhabi's position as a critical player in the global pharmaceutical industry, but also drive economic growth and job creation for Emirati citizens in the healthcare and logistics sectors."
As part of the agreement, the entities will work together to ensure timely access to innovative healthcare products for patients across the region, enhancing Abu Dhabi's role in global pharmaceutical supply chains. Aligned with the Emirate's economic aspirations, the collaboration is expected to attract significant investment in healthcare and logistics, promoting sustainable economic growth and diversification within the healthcare and life sciences sectors. The MoU also includes plans to support local manufacturing and packaging of pharmaceutical and biotechnology products, in addition to local capability enhancement.
" Abu Dhabi has made supporting the healthcare and life sciences industry a strategic priority, benefiting our nation and the world. Today,
Abu Dhabi stands as a leading hub in this field, with advanced infrastructure and supportive regulations enabling a vibrant community of health-tech companies."
, said: " Etihad Cargo is committed to supporting Abu Dhabi's vision of becoming a global hub for healthcare and life sciences distribution. This MoU, in partnership with the Department of Health – Abu Dhabi , ADIO and KEZAD is a major step towards enhancing the UAE's strategic importance in the global pharmaceutical supply chain and ensuring greater access to innovative healthcare products for patients in the region and beyond."
"At KEZAD Group, we are thrilled to be part of this landmark agreement. The collaboration between the Department of Health – Abu Dhabi , ADIO, Etihad, and AD Ports Group represents a significant step forward in establishing Abu Dhabi as a premier global hub for pharmaceutical and life sciences distribution. This partnership will enhance Abu Dhabi's regional and global competitiveness and ensure timely access to innovative healthcare products by leveraging KEZAD Group's strategic location, world-class logistics infrastructure, and robust investment environment."
Photo - https://mma.prnewswire.com/media/2433329/Department_of_Health_Abu_Dhabi.jpg
View original content:https://www.prnewswire.co.uk/news-releases/abu-dhabi-is-underway-to-become-a-global-pharmaceutical-and-life-science-distribution-hub-302167133.html